AsianInvesterAsianInvester

Indian pharma companies gear up to fight bird flu

Can Cipla do for bird flu what it has already done for Aids?
Google the words Tamiflu and India on any pharma or life sciences blog and the plans of various Indian pharmaceutical majors (Cipla, Ranbaxy, Nicholas Piramal) to produce a version of Tamiflu will be among the topics being hotly discussed. Some of the more forthright sites such as www.buytamiflu.org, for example, suggest that, "taking star anise to prevent bird flu is not a good idea." This blog is one of many to be openly supportive of Cipla's stated intention to produce a generic…
Sign In to Your Account
Access Exclusive AsianInvestor Content!
Please sign in to your subscription to unlock full access to our premium AI resources.

Free Registration & 7-Day Trial
Register now to enjoy a 7-day free trial—no registration fees required. Click the link to get started.
Note: This free trial is a one-time offer.
Questions?
If you have any enquiries or would like a quote for a team or company licence, please contact us at [email protected]. Our subscription team will be happy to assist you.